CN1067888C - 'Ganyankang' oral liquid-for treating hepatitis and preparation method - Google Patents
'Ganyankang' oral liquid-for treating hepatitis and preparation method Download PDFInfo
- Publication number
- CN1067888C CN1067888C CN97106832A CN97106832A CN1067888C CN 1067888 C CN1067888 C CN 1067888C CN 97106832 A CN97106832 A CN 97106832A CN 97106832 A CN97106832 A CN 97106832A CN 1067888 C CN1067888 C CN 1067888C
- Authority
- CN
- China
- Prior art keywords
- medicament
- hepatitis
- treatment
- patients
- take
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a prescription of a fast-effect medicament for treating hepatitis, and a preparation and administration method thereof. Virgate wormwood, giant knotweed rhizome, isatis root and the like are added with water and decocted to condensed liquid added with diammonium glycyrrhizinate and biphenyl diester for patients with hepatitis to take. People take the medicament for three times, 20 ml for each time, and eight days is a course of treatment. After patients take the medicament, the liver function index can be quickly darkened. Patients with light case only need to take the medicament for a course of treatment, and patients with severe case can recover after the medicament is taken for 3 to 4 courses of treatment. Patients do not need to take an injection or be in hospital by the method, and a large quantity of expenses is saved. The medicament has the advantages of no toxic or side effect, low price and convenient use, and furthermore, the medicament is an ideal medicament for treating various kinds of hepatitis.
Description
The present invention relates to the field of Chinese medicines, be specially adapted to after taking, can make the normal a kind of Chinese herbal and crude drugs preparations of liver function recovery within a short period of time with Chinese herbal and crude drugs preparations treatment acute hepatitis, chronic hepatitis, alcoholic hepatitis, toxic hepatitis, drug induced hepatitis.
The hepatitis of having found in the world at present has polytypes such as first, second, third, fourth, penta, heptan, the medicine that is used for the treatment of hepatitis both at home and abroad is also a lot, Chinese medicine class, Western medicine class, Chinese and Western are arranged in conjunction with the medicine class, not following tens of kinds of kinds, these medicines all have certain curative effect to treatment hepatitis, but following shortcoming is also arranged: the one, and the course of treatment is long, the medicine clothes that have 1 month, the medicine that has will be obeyed two months, and the medicine that also has must be obeyed just positive effect in three months; The 2nd, treatment is tired, and the medicine that has is with the method for intravenous drip medicinal liquid to be failed people's human body, and the medicinal liquid that has then needs intramuscular injection, have an injection every day, also has Chinese herbal medicine then to need morning and afternoon every day and decocts into the medicinal liquid clothes, and is very inconvenient; The 3rd, the expense height, patient's cost of hospitalization, vein loading liquid take, muscle is had an injection expense, expenses for medicine, the course of treatment is long, medical expense is high.
The objective of the invention is to: provide a kind of Chinese herbal medicine to make oral liquid, hepatitis is obeyed every day on time, hepatitis the lighter obeyed for 1 course of treatment (8 days), it is normal that liver function just can be recovered, weight person only needs the 3-4 course of treatment (24-32 days) to get final product rehabilitation, and the medicine that overcomes present treatment hepatitis exists the length course of treatment, weak curative effect, defective that expense is high.
Technical scheme of the present invention is: make oral liquid with Chinese herbal medicine and take for hepatitis.
1, raw material and consumption thereof: Herba Sedi Linearis 30g, BIANDIXIANG 30g, Herba Hyperici Japonici 30g, Rohdea japonica 30g, Herba Centellae 30g, PINGDIMU 30g, polygoni cuspidati,radix 30g, Herba Salviae Chinensis 30g, Herba Artemisiae Scopariae 60g, Radix Isatidis 30g, Poria 30g, Radix Glycyrrhizae 20g, Fructus Schisandrae Chinensis 20g, diammonium glycyrrhizinate 600mg, bifendate 67.5mg.
2, formulation preparation method: it is clean that the said herbal medicine roguing is weighed, and adds water 500 milliliters, places non-metallic vessel to decoct to 60 milliliters of dopes, gets its 60 milliliters of dopes, adds diammonium glycyrrhizinate 600mg, bifendate 67.5mg, bottling, sealing.
3, usage: oral 20 milliliters of hepatitis 1 time, day clothes three times.
Curative effect exemplifies:
1, patient Zhang Jinhua, the man, 23 years old, the Huaiyin City cigarette worker of factory, health check-up in 94 years is looked into after " two double " discovery " great three positive ", and liver function AST, ALT are unusual repeatedly, 100
uAbout/the L, used many Chinese medicines, Western medicine, but it is undesirable to fall enzyme, through with oral 20 milliliters of this medicinal liquid 1 time, day clothes three times serve on for 1 course of treatment (8 days), and liver function recovery is normal.
2, Shu Jinzhong, the man, 40 years old, Tang Gou people from town, Huaiyin City Guannan County suffered from hepatitis B 5 years, checked liver function AST 710 in May, 95
u/ L, ALT 926
u/ L, TBILI 75 μ MOL/L obey this medicinal liquid 1 course of treatment (8 days), and the check liver function significantly takes a turn for the better, and obeys for 1 course of treatment (8 days) again, and liver function recovery is normal, and hepatitis symptom disappears.
3, Hua Minfu, the man, 42 years old, the worker of three-tree township, Huaiyin City Huaiyin county supply and marketing cooperative, suffer from hepatitis B 8 years surplus, look into liver function AST 1400 in July, 95
u/ L, ALT 1970
u/ L, TBILI 102 μ MOL/L because of financial difficulties, can not be in hospital, and obey this medicinal liquid 3 courses of treatment (24 days), and liver function recovery is normal.
4, Zhu Xuejun, the man, 39 years old, Huaiyin City Qingpu District Yan He township flood was jumped the village peasant, suffer from hepatitis B 6 years surplus, yellowish urine is looked into liver function AST1610 like strong tea water
u/ L, ALT 21100
u/ L, TBILI 197.6 μ MOL/L, because of financial difficulties, can't hospitalization, obey this medicinal liquid on April 21st, 96, the check liver function all took an evident turn for the better in per 8 days, obeyed for 4 courses of treatment (32 days) continuously, and liver function recovery is normal, and the whole body hepatitis symptom disappears.
This medicinal liquid has following advantage:
1, evident in efficacy: 356 routine hepatitis are obeyed this medicinal liquid, effective percentage 100%, cure rate 99.44%.
2, healing time is short: hepatitis " light-duty " 1-2 course of treatment, " plain edition " 2-3 course of treatment." heavy type " 3-4 course of treatment, just can recover normal.
3, treatment is convenient: each oral 20 milliliters of medicinal liquid (bite-size), and do not need hepatitis to decoct Chinese medicine, need not to have an injection, hang the water treatment.
4, expense is cheap: complete faster because treatment time is short, therefore reduce dosage, and alleviate the expenses for medicine burden, " heavy type " hepatitis can be in and be taken medicine, and does not need hospitalization, saves hospitalization cost, does not need to have an injection, hang water, saves a large amount of medical expenses.
Claims (2)
1, a kind of medicinal liquid for the treatment of hepatitis is characterized in that it is to be made by the raw material of following consumption: Herba Sedi Linearis 30g, BIANDIXIANG 30g, Herba Hyperici Japonici 30g, Rohdea japonica 30g, Herba Centellae 30g, PINGDIMU 30g, polygoni cuspidati,radix 30g, Herba Salviae Chinensis 30g, Herba Artemisiae Scopariae 60g, Radix Isatidis 30g, Poria 30g, Radix Glycyrrhizae 20g, Fructus Schisandrae Chinensis 20g diammonium glycyrrhizinate 600mg, bifendate 67.5mg.
2, the preparation method of treatment hepatitis medicinal liquid as claimed in claim 1, it is characterized in that: weigh the said herbal medicine roguing clean, add 500 milliliters in water, place non-metallic vessel to decoct to 60 milliliters of dopes, get its 60 milliliters of dopes and add diammonium glycyrrhizinate 600mg, bifendate 67.5mg, bottling, sealing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97106832A CN1067888C (en) | 1997-01-24 | 1997-01-24 | 'Ganyankang' oral liquid-for treating hepatitis and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97106832A CN1067888C (en) | 1997-01-24 | 1997-01-24 | 'Ganyankang' oral liquid-for treating hepatitis and preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1188657A CN1188657A (en) | 1998-07-29 |
CN1067888C true CN1067888C (en) | 2001-07-04 |
Family
ID=5169039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN97106832A Expired - Fee Related CN1067888C (en) | 1997-01-24 | 1997-01-24 | 'Ganyankang' oral liquid-for treating hepatitis and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1067888C (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100366283C (en) * | 2006-08-17 | 2008-02-06 | 齐鸽子 | Compositions comprising biphenyldicarboxylate |
CN100366282C (en) * | 2006-08-17 | 2008-02-06 | 齐鸽子 | Medicinal compositions comprising biphenyldicarboxylate |
CN100363040C (en) * | 2006-08-17 | 2008-01-23 | 张娜 | Medicinal compositions comprising biphenyldicarboxylate |
CN100367986C (en) * | 2006-08-17 | 2008-02-13 | 陈乃车 | Cooperative drug comprising biphenyldicarboxylate |
CN100367980C (en) * | 2006-08-17 | 2008-02-13 | 陈乃车 | Cooperative compositions comprising biphenyldicarboxylate |
CN100356962C (en) * | 2006-08-17 | 2007-12-26 | 张娜 | Traditional Chinese medicine and western medicine compositions comprising biphenyldicarboxylate |
CN100363041C (en) * | 2006-08-17 | 2008-01-23 | 陈乃车 | Traditional Chinese medicine and western medicine cooperative compositions comprising biphenyldicarboxylate |
CN100345585C (en) * | 2006-08-17 | 2007-10-31 | 汪敏 | Drug comprising biphenyldicarboxylate |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1077384A (en) * | 1993-01-20 | 1993-10-20 | 吴传福 | The manufacture method of willow-dandelion tablet for preventing hepatitis |
CN1078897A (en) * | 1993-01-03 | 1993-12-01 | 于灵惠 | " hepatitis B health " Chinese medicine preparation and preparation technology thereof |
-
1997
- 1997-01-24 CN CN97106832A patent/CN1067888C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1078897A (en) * | 1993-01-03 | 1993-12-01 | 于灵惠 | " hepatitis B health " Chinese medicine preparation and preparation technology thereof |
CN1077384A (en) * | 1993-01-20 | 1993-10-20 | 吴传福 | The manufacture method of willow-dandelion tablet for preventing hepatitis |
Also Published As
Publication number | Publication date |
---|---|
CN1188657A (en) | 1998-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102755594B (en) | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof | |
CN102614440B (en) | Multi-herb antibacterial liquid | |
CN1057451C (en) | Children coryza medicine and preparing method | |
CN1117391A (en) | Medicine for treating rheumatic disease | |
CN100443112C (en) | Medicine for treating gout and gout arthritis | |
CN1067888C (en) | 'Ganyankang' oral liquid-for treating hepatitis and preparation method | |
CN101596230A (en) | A kind of pharmaceutical composition for the treatment of hepatopathy | |
CN100382838C (en) | Chinese medicine for treating blood stagnation disease | |
CN101919944A (en) | Traditional Chinese medicine compound, preparation method and application thereof | |
CN101204532B (en) | Medicine for prostate disease and preparation method thereof | |
CN1059556C (en) | Compound bufonin of bufo gargarizans | |
CN1041495C (en) | External application medicine for curing hepatic disease | |
CN102258723B (en) | Traditional Chinese medicine composition for treating chronic hepatitis B | |
CN1078897A (en) | " hepatitis B health " Chinese medicine preparation and preparation technology thereof | |
CN1069058C (en) | Compound medicament for treating chronic pelvic inflammation | |
CN101040650A (en) | Health-care type ganoderma lucidum combined tea | |
CN1333026A (en) | Medicine for treating hyperplasia of mammary glands | |
CN102085350A (en) | Medicament for treating arthritis and preparation method thereof | |
CN1212147C (en) | Compound preparation of Chinese herbal medicine for treating chronic prostatitis and its preparing method | |
CN1248465A (en) | Method for producing Anruneixiao medicinal liquid | |
CN101879227B (en) | Chinese medicinal composition for treating protrusion of lumbar intervertebral disci and preparation method thereof | |
CN1422639A (en) | Dral medicine for treating rheumatism and atrophic diseases | |
CN1193787C (en) | Immunoregulator for preventing and treating AIDS | |
CN1092068C (en) | Hongchanjinu (liquid) soluble granules | |
CN1064541C (en) | Medicine for treating gynecological chronic inflammation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |